Lung cancer statistics

Lung cancer is the most commonly diagnosed cancer in Canada (excluding non-melanoma skin cancers). It is the leading cause of death from cancer for both men and women in Canada.

To provide the most current cancer statistics, statistical methods are used to estimate the number of new cancer cases and deaths until actual data become available.

Incidence and mortality

Incidence is the total number of new cases of cancer. Mortality is the number of deaths due to cancer.

It is estimated that in 2021:

  • 29,600 Canadians will be diagnosed with lung cancer. This represents 13% of all new cancer cases in 2021.

  • 21,000 Canadians will die from lung cancer. This represents 25% of all cancer deaths in 2021.

  • 14,800 men will be diagnosed with lung cancer and 10,800 will die from it.

  • 14,800 women will be diagnosed with lung cancer and 10,300 will die from it.

  • On average, 81 Canadians will be diagnosed with lung cancer every day.

  • On average, 58 Canadians will die from lung cancer every day.

Estimated Canadian lung cancer statistics (2021)

Category

Males

Females

New cases

14,800

14,800

Deaths

10,800

10,300

5-year net survival (estimates for 2015 to 2017)

19%

26%

Diagram of percentage of lung cancer cases to all other cancers 2021
Diagram of percentage of lung cancer cases to all other cancers 2021
Diagram of the percentage of lung cancer deaths to all other cancer deaths 2021
Diagram of the percentage of lung cancer deaths to all other cancer deaths 2021

Chances (probability) of developing or dying from lung cancer

It is estimated that about 1 in 15 Canadian men will develop lung cancer during their lifetime and 1 in 18 will die from it.

It is estimated that about 1 in 15 Canadian women will develop lung cancer during their lifetime and 1 in 20 will die from it.

For more information about cancer statistics, go to Canadian Cancer Statistics.

Expert review and references

  • Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics 2021. Canadian Cancer Society; 2021.